Acquisitions - Summary of Total Consideration Transferred of Acquisition Date (Details) - Elevated Softgels $ in Thousands |
May 13, 2024
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Cash | $ 41 |
| Common shares | 871 |
| Earn-out | 100 |
| Total consideration transferred | $ 1,012 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Fair value at acquisition date of asset transferred, liability incurred, equity interest issued or issuable by acquirer, and equity interest in acquiree held by acquirer immediately before acquisition date in business combination achieved in stages. Includes, but is not limited to, instrument or interest issued or issuable by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|